← Leaderboards
Anna R Hemnes
Vanderbilt University Medical Center
$10,524,693
Attributed
$14,211,239
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,955,117 · 10
FDA$1,600,000 · 1
By mechanism
R01$11,370,732 · 4
P01$8,343,878 · 1
U01$1,456,063 · 1
K08$627,480 · 1
K24$458,576 · 1
R03$175,000 · 1
Top collaborators
- Evan L Brittain8 shared
- John Hughes Newman6 shared
- Eric Douglas Austin4 shared
- Bradley Maron4 shared
- James E Loyd2 shared
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Jonathan Harvey Soslow$5,426,669
- Deepak Gupta$5,627,629
- Evan L Brittain$13,630,303
- Larry W. Markham$463,617
- Ravi Shah$14,155,608
Others in their field
Top investigators on “Pulmonary Arterial Hypertension”
- Marlene Rabinovitch · Stanford University$37,720,523
- Steven M Kawut · Columbia University Health Sciences$25,762,724
- Jason X.-J. Yuan · University Of California, San Diego$23,310,307
- Mark Thomas Gladwin · Clinical Center$17,771,315
- William C Nichols · Children'S Hospital Med Ctr (Cincinnati)$16,040,000
- Vasan S. Ramachandran · Boston University Medical Campus$14,020,252
Research focus
Pulmonary Arterial HypertensionResponseBlood VesselsDiagnosisPulmonary HypertensionLungPhenotypeMolecularMetabolicGeneticPrecision MedicineAffectPathway InteractionsCohortInsulin ResistanceFuturePulmonary Artery StructureHemodynamicsGrantBaseBiologyGenomicsAnimal ModelPharmaceutical Preparations
Grant awards (46)
Genomic and Circulating Predictors of PAH response$785,069
R01 · FY2025 · HL · contact PI
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension$699,718
R01 · FY2025 · HL
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2025 · FD
Mentorship in Pulmonary Vascular Disease$114,644
K24 · FY2025 · HL · contact PI
Genomic and Circulating Predictors of PAH response$785,069
R01 · FY2024 · HL · contact PI
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension$685,723
R01 · FY2024 · HL
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2024 · FD
Mentorship in Pulmonary Vascular Disease$114,644
K24 · FY2024 · HL · contact PI
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension$653,505
R01 · FY2023 · HL
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2023 · FD
FLI1 in Pulmonary Arterial Hypertension$175,000
R03 · FY2023 · TR · contact PI
Mentorship in Pulmonary Vascular Disease$114,644
K24 · FY2023 · HL · contact PI
2023 Grover Conference$10,000
R13 · FY2023 · HL · contact PI
Network Medicine and Systems Pharmacology to Advance Precision Medicine in Combined Pulmonary Hypertension$798,826
R01 · FY2022 · HL
Genomic and Circulating Predictors of PAH response$622,064
R01 · FY2022 · HL · contact PI
Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals$400,000
R01 · FY2022 · FD
Mentorship in Pulmonary Vascular Disease$114,644
K24 · FY2022 · HL · contact PI
Hormonal, Metabolic and Signaling Interactions in PAH$1,678,313
P01 · FY2021 · HL · contact PI
Genomic and Circulating Predictors of PAH response$622,064
R01 · FY2021 · HL · contact PI
Genomic and Circulating Predictors of PAH response$171,248
R01 · FY2021 · HL · contact PI
Hormonal, Metabolic and Signaling Interactions in PAH$1,652,537
P01 · FY2020 · HL · contact PI
Genomic and Circulating Predictors of PAH response$622,064
R01 · FY2020 · HL · contact PI
Hormonal, Metabolic and Signaling Interactions in PAH$1,653,141
P01 · FY2019 · HL · contact PI
Genomic and Circulating Predictors of PAH response$622,064
R01 · FY2019 · HL · contact PI
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$378,456
R01 · FY2019 · HL · contact PI
Hormonal, Metabolic and Signaling Interactions in PAH$1,654,352
P01 · FY2018 · HL
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$431,210
R01 · FY2018 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$300,898
U01 · FY2018 · HL · contact PI
Hormonal, Metabolic and Signaling Interactions in PAH$1,705,535
P01 · FY2017 · HL
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$514,988
R01 · FY2017 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$304,885
U01 · FY2017 · HL · contact PI
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$158,000
R01 · FY2017 · HL · contact PI
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$591,282
R01 · FY2016 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$308,792
U01 · FY2016 · HL · contact PI
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$17,284
R01 · FY2016 · HL · contact PI
Lipid Deposition in the Right Ventricle in Pulmonary Arterial Hypertension$612,098
R01 · FY2015 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$188,960
U01 · FY2015 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$117,026
U01 · FY2015 · HL · contact PI
A molecular phenotype of combined pulmonary hypertension$235,502
U01 · FY2014 · HL · contact PI
Gender differences and endothelin responses in right ventricular afterload stress$125,496
K08 · FY2012 · HL · contact PI
Gender differences and endothelin responses in right ventricular afterload stress$125,496
K08 · FY2011 · HL · contact PI
Gender differences and endothelin responses in right ventricular afterload stress$125,496
K08 · FY2010 · HL · contact PI
Gender differences and endothelin responses in right ventricular afterload stress$125,496
K08 · FY2009 · HL · contact PI
Gender differences and endothelin responses in right ventricular afterload stress$125,496
K08 · FY2008 · HL · contact PI
PDE5 Inhibition Modulates Right Ventricular Failure$58,036
F32 · FY2006 · HL · contact PI
PDE5 Inhibition Modulates Right Ventricular Failure$55,352
F32 · FY2005 · HL